OTC •
Healthcare •
Medical Devices •
Quote as of 07/21/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeOTC
Market Capitalization33.07 mln
Float1,049 mln
Earnings Date08/13/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.3
Reliable
Relative Strength
7
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
ROE
-98.59
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2009 and based in Malmö, Sweden, Acarix AB builds technology that helps doctors quickly determine whether a patient is unlikely to have coronary artery disease. Its main product, the CADScor System, listens to subtle sounds from the heart and applies artificial intelligence to support faster clinical decisions without sending patients for more extensive testing. The company markets this technology across several countries, including the United States, Germany, the United Kingdom, and a number of Nordic and European markets.
